This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Kymab Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Lorenz C Hofbauer: Innovator in Sclerosing Disease Treatment
Introduction
Lorenz C Hofbauer is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of sclerosing diseases. His innovative work has the potential to impact many lives.
Latest Patents
Hofbauer holds a patent for the "Use of the extracellular domain of transferrin receptor 2 for the diagnosis and treatment of primary or secondary sclerosing diseases." This invention relates to a protein that can be utilized in diagnosing and treating these diseases. It includes a fusion protein, nucleotide sequence, vector, and a pharmaceutical composition aimed at improving patient outcomes.
Career Highlights
Hofbauer is currently associated with Kymab Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Collaborations
Some of his notable coworkers include Martina Rauner and Uwe Platzbecker, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Lorenz C Hofbauer's contributions to the field of medicine through his patent and ongoing work at Kymab Limited highlight his role as an influential inventor. His research holds promise for improving the diagnosis and treatment of sclerosing diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile